The unfolded protein response (UPR) maintains protein-folding homeostasis in the endoplasmic reticulum (ER) and has been implicated as both beneficial and detrimental to flavivirus infection. Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), a sensor of the UPR, is commonly associated with antiviral effects during mosquito-borne flavivirus (MBFV) infection, but its relation to tick-borne flavivirus (TBFV) infection remains largely unexplored. In this study, we identified changes in UPR and autophagic activity during Langat virus (LGTV) infection. LGTV robustly activated UPR and altered autophagic flux. Knockdown of endogenous PERK in human cells resulted in increased LGTV replication, but not that of closely related Powassan virus (POWV). Finally, on examining changes in protein levels of components associated with UPR and autophagy in the absence of PERK, we could show that LGTV-infected cells induced UPR but did not lead to expression of C/EBP homologous protein (CHOP), an important downstream transcription factor of multiple stress pathways. From these data, we hypothesize that LGTV can antagonize other kinases that target eukaryotic initiation factor 2α (eIF2α), but not PERK, implicating PERK as a potential mediator of intrinsic immunity. This effect was not apparent for POWV, a more pathogenic TBFV, suggesting it may be better equipped to mitigate the antiviral effects of PERK.
The unfolded protein response (UPR) maintains protein-folding homeostasis in the endoplasmic reticulum (ER) and has been implicated as both beneficial and detrimental to flavivirus infection. Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), a sensor of the UPR, is commonly associated with antiviral effects during mosquito-borne flavivirus (MBFV) infection, but its relation to tick-borne flavivirus (TBFV) infection remains largely unexplored. In this study, we identified changes in UPR and autophagic activity during Langat virus (LGTV) infection. LGTV robustly activated UPR and altered autophagic flux. Knockdown of endogenous PERK in human cells resulted in increased LGTV replication, but not that of closely related Powassan virus (POWV). Finally, on examining changes in protein levels of components associated with UPR and autophagy in the absence of PERK, we could show that LGTV-infected cells induced UPR but did not lead to expression of C/EBP homologous protein (CHOP), an important downstream transcription factor of multiple stress pathways. From these data, we hypothesize that LGTV can antagonize other kinases that target eukaryotic initiation factor 2α (eIF2α), but not PERK, implicating PERK as a potential mediator of intrinsic immunity. This effect was not apparent for POWV, a more pathogenic TBFV, suggesting it may be better equipped to mitigate the antiviral effects of PERK.
Entities:
Keywords:
Langat virus; PERK; autophagy; tick-borne flavivirus; unfolded protein response
Flaviviruses are a diverse family of small, enveloped viruses, transmitted primarily by arthropod vector hosts. These agents require several cellular systems and pathways to complete their lifecycle [1]. The majority of studies into flavivirus–host cell interactions have focused on the mosquito-borne flaviviruses (MBFVs), such as West Nile virus (WNV) and dengue virus (DENV). However, the incidence of tick-borne flaviviruses (TBFVs) such as Powassan virus (POWV) [2,3,4,5] and tick-borne encephalitis virus (TBEV) [6,7] is rising due to a number of ecological and climatic factors [8]. POWV and TBEV can cause debilitating encephalitic disease resulting in death or long-term neurological sequelae and have no specific treatments beyond palliative care [9]. The related and naturally attenuated TBFVLangat virus (LGTV), has proven a valuable model system to study the highly neurovirulent TBFVs such as POWV and TBEV [10].Flavivirus genome replication and translation occurs primarily on membranes of the endoplasmic reticulum. This process places significant stress on the infected cell, because translation of the viral polyprotein is not subject to the same stringent intrinsic control as are most host proteins. Cells respond to the accumulation of proteins in the endoplasmic reticulum (ER) by activation of the unfolded protein response (UPR). The UPR is an ancient system used by eukaryotic cells to respond to translational stress, and orthologous systems are present in most eukaryotes, spanning yeast to humans [11,12,13]. The UPR maintains conditions within the ER lumen that are ideal for appropriate protein folding using a luminal chaperone, binding immunoglobulin protein (BiP) and three proteins embedded in the ER membrane, including PKR-like ER Kinase (PERK) [14]. In non-stress situations, BiP non-covalently associates with these proteins keeping them in a dormant state. However, in the presence of unfolded peptides, BiP dissociates from these sensors and permits downstream signaling [15]. PERK phosphorylates eukaryotic translation initiation factor 2α (eIF2α), which leads to rapid attenuation of global protein synthesis. eIF2α phosphorylation is common to multiple cellular stress pathways including that of protein kinase R (PKR), a sensor of dsRNA commonly activated during viral infection. Some transcripts are able to bypass the eIF2α-mediated translational block, including activating transcription factor 4 (ATF4), which subsequently activates expression of CCAAT-enhancer-binding protein homologous protein (CHOP), growth arrest and DNA damage inducible protein 34 (GADD34), and other proteins responsible for modulating amino acid metabolism, redox homeostasis, and activation of apoptosis [16,17]. PERK, along with the other two sensors, coordinately functions to maintain ER homeostasis.Several families of enveloped viruses, including flaviviruses, activate the UPR [18,19,20,21,22]. MBFVs, including DENV, WNV, and Japanese encephalitis virus (JEV), increase expression of BiP, a common marker of UPR activity. It is undetermined whether this is due to some direct action by the virus itself or is simply a response to the high peptide burden of infection [23,24,25]. PERK knockout or knockdown studies using mouse embryonic fibroblast (MEF) cells have shown that PERK plays a largely antiviral role in MBFV replication [25,26,27]. One study, however, suggested that PERK might actually aid DENV replication by promoting autophagosome formation and turnover [28]. The TBFVs have been the subject of less inquiry. TBEV has been shown to activate the inositol requiring enzyme 1 (IRE1) arm of the UPR leading to priming of the innate immune system, but no role has yet been assigned to PERK [29,30].The UPR is not the only homeostatic system the cell employs to regulate protein folding. Autophagy is another highly conserved cellular pathway used to manage cell resources via the recycling of intracellular components, ranging from cytosolic peptides to entire organelles. Three types of autophagy are known to occur in mammalian cells: microautophagy, macroautophagy, and chaperone-mediated autophagy (CMA). While microautophagy and CMA degrade substrates on a peptide level, macroautophagy is capable of recycling large amounts of cellular material, including damaged organelles and membranes. When macroautophagy occurs, the cell assembles a double-membraned structure called an autophagosome. As this structure forms, the cytosolic protein, microtubule-associated protein light chain 3 (LC3), is lipidated with phosphatidylethanolamine and used to decorate the interior of the forming autophagosome where it serves as an attachment site for cargo receptors, such as SQSTM1/p62 [31,32]. LC3 is a commonly assayed marker of autophagic activity. Because only the lipidated form (LC3-II) can be inserted into autophagosome membranes, an autophagic state can be inferred by comparing the inactive unlipidated (LC3-I) and active lipidated (LC3-II) forms [33]. Once the autophagosome has engulfed the target and closed, it fuses with a lysosome to create the autolysosome, in which the contents are degraded. Autophagy is crucial not only for component recycling in the cell but also for directly modulating innate immune function, including NF-κB response and major histocompatibility complex (MHC) 1 and 2 antigen presentation [34]. Autophagy has different effects on MBFVs [35] ranging from pro-viral (JEV, DENV, and Zika virus [36,37,38,39]), to antiviral (DENV [40]), to no effect (WNV [41,42]) depending on cell type and stage of infection.In this paper, we explored the role of PERK in the TBFV replication cycle, using LGTV as a model. First, we measured UPR signaling and PERK-mediated activity by western blot. We next generated a PERK-knockdown HEK293T cell line using CRISPR technology and used it to interrogate the function of PERK in viral infection. Finally, we looked at several upstream and downstream targets of PERK as well as the autophagy pathway to determine potential mechanisms of restriction. We additionally found that LGTV is able to antagonize CHOP expression independent of PERK, providing preliminary evidence of PERK as an intrinsic immune factor against TBFV infection.
2. Materials and Methods
2.1. Cell Culture and Viruses
HEK293T and Vero cells (ATCC, Manassas, VA, USA) were maintained in Dulbecco’s minimal essential media ((DMEM), Life Technologies, Carlsbad, CA, USA) supplemented with 50 μg/mL gentamycin and 10% fetal bovine serum (FBS) at 37 °C in 5% CO2.Langat virus (TP21 strain) and Powassan virus (lineage I LB Prototype strain; originally obtained from Robert Tesh, University of Texas Medical Branch) were prepared as previously described [43,44].
2.2. Antibodies
Antibodies used in this study are as follows: PERK (Cell Signaling, C33E10, Danvers, MA, USA), BiP (Cell Signaling, C50B12, Danvers, MA, USA), CHOP (Cell Signaling, L63F7, Danvers, MA, USA), β-actin (Sigma Aldrich, A5441, St. Louis, MO, USA), LC3 (Enzo Life Sciences, 5F10, Farmingdale, NY, USA), LGTV envelope (E) (a kind gift from Dr. Connie Schmaljohn, USAMRID, Fort Detrick, Frederick, MD, USA, 11H12), LGTV nonstructural protein 3 (NS3) (custom polyclonal prepared by Aves Labs (Tigard, OR, USA), sequence: CZRDIREFVSYASGRR), ATF6 (Abcam, ab122897, Cambridge, MA, USA), Alexa Fluor 594-conjugated anti-mouse and Alexa Fluor 647-conjugated anti-chicken secondaries (Thermo Fisher, Waltham, MA, USA), HRP-conjugated anti-mouse and anti-rabbit secondaries (Jackson ImmunoResearch, West Grove, PA, USA).
2.3. Generation of CRISPR Knockdown Cell Line
HEK293T cells were seeded in six-well plates to a density of 4 × 105 cells per well. A plasmid containing the Cas9 gene, mDASHER-GFP, and sgRNA targeting exon 5 of PERK (Hs:2: 88,890,383–88,890,422) (Atum, Newark, CA, USA) was transfected at 1 µg per well with Effectene transfection reagent (Qiagen, Germantown, MD, USA) according to the manufacturer’s protocols. The cells were incubated in the transfection mixture at 37 °C for 24 h. Transfected cells were examined for GFP expression using an Axio Vert.A1 microscope (Zeiss, White Plains, NY, USA) equipped with a PhotoFluor LM-75 light source (89 North, Williston, VT, USA) and an ET-GFP (FITC/Cy2) filter (Chroma, Bellows Falls, VT, USA). The transfection mixture was removed and replaced with fresh media. Following another 24 h incubation, transfected cells were pooled and plated into single-cell colonies on 96-well plates. Following eight days of growth, isolated colonies were selected and expanded. Subclones were evaluated for PERK expression using western blot.Additionally, the nucleotide sequence at the putative edit site in this cell line was characterized at both a low (p. 13) and high passage (p. 108) number to monitor the knockout. Briefly, genomic DNA was extracted (DNAzol, Thermo Scientific, Waltham, MA, USA) from a low or high passage number wild-type (WT) or CRISPR-treated cell and the editing locus was amplified by PCR (forward primer: 5′- GTGGAATTTCAGTGTTGGCCACTTTGAAC -3′, reverse primer: 5′- TGGTGTTAG GTACCTGGTACTCCC -3) producing an expected product of 248 bp (Phusion, New England Biolabs, Ipswich, MA, USA). The DNA was purified (QIAquick PCR purification kit, Qiagen, Germantown, MD, USA), quantified (Qubit dsDNA HS Assay, Thermo Fisher, Waltham, MA, USA), and sequenced using MiSeq technology at Massachusetts General Hospital, Center for Computational and Integrative Biology. These cells will be referred to as PERKLOW for the remainder of this paper.
2.4. Cell Viability
Cell viability was evaluated using a resazurin-based assay measuring cellular reducing potential, a proxy for cell health. Wild-type (WT) or PERKLOW HEK293T cells were plated on poly-lysine (Sigma-Aldrich, St. Louis, MO, USA)-treated 96-well plates at a density of 1 × 104 cells per well. At 0, 24, 48, and 72 h post culture, supernatant was removed and replaced with new media containing alamarBlue reagent (AbD Serotec, Kidlington, UK) at a 1:10 dilution [45]. Cells were then incubated for 2 h at 37 °C. Absorbance was measured at 570 nm using a Molecular Devices SpectraMax Plus 384 plate reader and SoftMax Pro v6.5 software [46]. Data shown are results of two biological replicates with three technical replicates each.
2.5. Virus Quantification
WT or PERKLOW cells were seeded on poly-lysine (Sigma-Aldrich, St. Louis, MO, USA)-treated 96-well plates at a density of 1 × 104 cells per well. After 16 h, cells were infected with LGTV or POWV, multiplicity of infection (MOI) = 1. Supernatants were collected every 24 h post infection (hpi), starting at 0 hpi and ending at 72 hpi. An immunofocus assay was used to quantify infectious LGTV and POWV release as previously described [43,44]. Data shown are results of three biological replicates with at least two technical replicates.
2.6. Intracellular Genome Quantification
RNA was isolated from LGTV-infected cells from the previously described infection time-course experiment. After infectious supernatant was removed, cells were washed three times with Dulbecco’s phosphate buffered saline (DPBS) (Life Technologies, Carlsbad, CA, USA). RNA was then isolated using an RNeasy kit (Qiagen, Germantown, MD, USA) following the manufacturer’s instructions. Total RNA was quantified using a NanoDrop spectrophotometer (Thermo Fisher, Waltham, MA, USA), and cDNA was generated using iScript cDNA synthesis kit (BioRad, Hercules, CA, USA), using random hexamers for (+) strand genome generation and (-) strand specific primers for (-) strand genome generation. Total genome copies were quantified by qPCR using a LGTV plasmid stock of known concentration as previously described [47]. Data shown are results of three biological replicates with three technical replicates each.
2.7. Protein Analysis
HEK293T cells were seeded to a density of 8 × 105 cells per well in six-well plates. After 16 h, cells were mock infected with complete media or infected with LGTV at an MOI of 10. For time-course studies, whole cell lysates were collected at 24, 48, and 72 hpi. WT cells treated with 10 µg/mL Tunicamycin (Sigma T7765, St. Louis, CA, USA) for 21 h prior to lysate harvest were used as a positive control for UPR activation assays. Cells were pelleted in DPBS and lysed using 300 μL radioimmunoprecipitation assay (RIPA) buffer (25 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100), and a cOmplete mini protease inhibitor cocktail (Roche, Basel, CH). Aliquots were saved for protein quantification via a Pierce BCA assay (Thermo Fisher Scientific, Waltham, MA, USA). Cold methanol (−20 °C) was added to samples at a ratio of 4:1. Following an incubation no shorter than 24 h at −80 °C, precipitated samples were spun at 16.2 × 103 relative centrifugal force (rcf) for 30 min to pellet protein. Methanol was then removed, and samples were reconstituted to 5 µg/µL concentration in 2× protein sample buffer (125 mM Tris, 6 mM EDTA, 10% SDS, 10% Glycerol, 0.04% bromophenol blue, 100 mM DTT) and incubated for 10 min at 95 °C.For preparation of samples to examine autophagy by western blot, supernatants were removed 24 hpi and replaced with either fresh complete media, Earle’s balanced salt solution (EBSS) media (Sigma Aldrich, St. Louis, MO, USA), DMEM plus 10 µM bafilomycin A1 (BafA1) (Sigma Aldrich, St. Louis, MO, USA), or EBSS plus 10 µM BafA1. After 4 h, the medium was removed from cultures and whole cell lysates were made as noted in the previous section.Proteins were separated by SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF) membranes by using an iBlot gel-transfer device (Thermo Fisher Scientific, Waltham, MA, USA). Membranes were blocked with 5% nonfat milk in Tris-buffered saline–0.5% Tween 20 (TBS-T) and then incubated with primary antibodies overnight at 4 °C. After three washes with TBS-T, the membranes were incubated with secondary horseradish peroxidase-conjugated antibodies, developed with ECL Plus Western chemiluminescent system (Thermo Fisher Scientific, Waltham, MA, USA) and exposed to film. Between 2 and 4 biological replicates of each blot were performed.
2.8. Immunofluorescence (IF) and Image Analysis
HEK293T cells were seeded to a density of 4 × 104 cells per well in eight-well Lab-Tek chambered glass slides pretreated with poly-D-lysine. After 16 h, cells were mock infected with complete media or infected with LGTV at an MOI of 10. Following 24 h, supernatant was replaced with fresh complete media, EBSS media, complete media plus 10 µM BafA1, or EBSS plus 10 µM BafA1. After 4 h, the medium was removed from cultures and examined by IF.Cells were fixed using cold 100% methanol for 15 min, quenched with 0.1% glycine in 1× PBS, permeabilized with 0.1% Triton-X 100 for 5 min, and blocked with 1% bovine serum albumin (BSA) in 1× PBS for 1 h. Primary antibodies against LC3 and LGTV nonstructural protein 3 were added overnight at 4 °C in 1× PBS plus 1% BSA. Secondary antibodies were added for 1 h in 1× PBS plus 1% BSA and cells were mounted in Prolong Gold antifade plus DAPI (Thermo Fisher, Waltham, MA, USA). Slides were imaged using a Zeiss LSM 710 confocal laser scanning microscope. Autophagosome analysis was performed in ImageJ. Briefly, cells per field of view were enumerated by DAPI segmentation and probable autophagosomes were called using LC3 signal using size and pixel-intensity parameters. Images are a result of one biological replicate in which more than 1500 individual cells were analyzed.
3. Results
3.1. LGTV Infection Activates the UPR
The UPR has been postulated to play a role in infections of several vector-borne flaviviruses, but no experiments to date have investigated a role in infections by LGTV. Therefore, we first examined whether LGTV activates the UPR. HEK293T cells were infected with LGTV, MOI = 10, and whole cell protein lysates were collected at 24, 48, and 72 hpi. BiP expression, a broad indicator of UPR activity [48], was measured by western blot. BiP levels increased notably throughout the infection time course (Figure 1A). This result demonstrated that LGTV infection robustly activated the UPR pathway. A slight increase in BiP expression was also observed in the mock sample at later time points.
Figure 1
The tick-borne flavivirus Langat virus (LGTV) infection activates host unfolded protein response (UPR) and autophagy pathways. (A) LGTV infection (MOI = 10) in HEK293T cells generated an increase in binding immunoglobulin protein (BiP) and CCAAT-enhancer-binding protein homologous protein (CHOP) expression, but not activating transcription factor 6 (ATF6) cleavage, suggesting active protein kinase R-like endoplasmic reticulum kinase PERK signaling. Tunicamycin (10 µg/mL) control included for BiP, ATF6, and CHOP. LGTV E expression increased throughout infection time course. (B) Basal autophagic flux of HEK293T cells measured by microtubule-associated protein light chain 3 (LC3)-I and LC3-II expression. Earle’s balanced salt solution (EBSS) starvation increases flux, depleting LC3-I and LC3-II. Blocking autolysosomal degradation with bafilomycin A1 (BafA1) increased the abundance of LC3-II, more so under EBSS starvation. Total signal normalized to mock control and reported below bands. (C) LGTV infection (MOI = 10) alters autophagic flux in HEK293T cells 24 hpi (hours post infection). Infected samples had higher overall LC3 expression, but the majority was unlipidated LC3-I, suggesting inhibition of LC3 lipidation. (D) Representative images of HEK293T cells treated with EBSS, BafA1, or LGTV infection. DAPI represented in blue, LC3 in green, and LGTV NS3 in red. Images acquired at 63x magnification. (E) Average autophagosomes per cell identified by LC3 fluorescent signal normalized to number of nuclei. Very few autophagosomes recorded in non-BafA1-treated samples.
To determine whether PERK was activated by LGTV infection, we measured levels of CHOP, a transcription factor able to bypass eIF2α-induced translation shutoff. (Figure 1A). CHOP can lead to deleterious outcomes including apoptosis [49] and we have previously described that LGTV infection induces a cytopathic effect in HEK293T cells [47]. Levels of CHOP increased as infection progressed compared to mock samples, while levels of PERK remained consistent (Figure 1A). ATF6 activation has also been reported to induce CHOP expression, so we measured ATF6 cleavage. We observed ATF6 cleavage in HEK293T cells following 21 h tunicamycin treatment, but not at any timepoint during LGTV infection. These data suggested that LGTV activated PERK, which subsequently induced production of CHOP. Thus, we have demonstrated that LGTV infection robustly and consistently activated the PERK arm of the UPR.
3.2. LGTV Infection Alters Autophagic Flux
Published studies have also linked PERK activation to autophagic regulation [50,51,52]. Autophagy has varied and apparently contradictory effects on flavivirus replication [35]. To evaluate the role of autophagy in LGTV infection, we chose to measure the level of LC3, a marker of autophagic flux. Under standard conditions, LC3 is present throughout the cytosol in a non-active unlipidated form, LC3-I. During autophagy, LC3-I is lipidated to form LC3-II, which has an active role in autophagosome formation. By measuring total LC3 abundance and then comparing relative quantities of unlipidated LC3-I and LC3-II, one can estimate the overall autophagic flux of a cell population.HEK293T cells were infected at an MOI of 10. After 24 h of infection, they were treated with complete DMEM or EBSS containing BafA1 or vehicle (DMSO) for 4 h. The EBSS media starves the cells and activates autophagy. This depletes both forms of LC3 as LC3-I is lipidated to LC3-II and LC3-II is degraded as the autophagosomes fuse with the lysosomes. BafA1 treatment inhibits autophagosome fusion, preventing degradation of the lipidated LC3-II. When EBSS starvation and BafA1 treatment are combined, LC3-I is still converted to LC3-II, but LC3-II is not degraded, resulting in a robust accumulation of LC3-II only. Whole-cell lysates were probed for LC3 to confirm these phenotypes with HEK293T cells (Figure 1B). We next examined LC3 expression in LGTV-infected cells. LGTV infection produced higher levels of LC3 as determined by band intensity. Yet, when we blocked autophagosome degradation, only a small accumulation of LC3-II was observed with the majority remaining in the unlipidated inactive LC3-I form, suggesting that LGTV is capable of antagonizing LC3 lipidation (Figure 1C).We examined autophagic activity by IF. During active autophagy, lipidated LC3-II accumulates in autophagosome membranes, corresponding to puncta in cell images. Cells were subjected to the same conditions as previously including EBSS starvation, LGTV infection, and BafA1 treatment, and then stained for LC3 (green) and LGTVNS3 (red). Autophagosomes were sparse in mock and virus-infected samples, with large accumulations only present in BafA1-treated samples. (Figure 1D,E). Our combined immunoblot and IF data suggest that the virus limits lipidation of LC3-I leading to a decrease in autophagosome formation and reduced autophagic flux.
3.3. PERK Has an Antiviral Effect on LGTV Replication
To further explore the role of PERK in TBFV infection, we knocked down PERK expression in HEK293 cells using CRISPR-Cas9 technology. We transfected HEK293T cells with a plasmid containing the Cas9 gene and an sgRNA pair targeting the fifth exon of PERK. Following 48 h, the bulk population was subcloned and individual clones were tested for PERK expression by western blot. While no clone exhibited a complete knockout phenotype, we selected one that had drastically reduced PERK expression (Figure 2A). MiSeq sequencing of exon 5 revealed four major edits corresponding to the predicted edit site as determined by the 20 nt gRNA and protospacer adjacent motif (PAM) sequence (Figure 2B). Alleles 1 and 2 represented the majority of reads and both contained deletions that led to premature stop codons. Allele 3 had a 15 nt deletion that did not shift the reading frame and allele 4 had a 4 nt insert also resulting in premature translation termination. Interestingly, sequencing of the same cell line at a higher passage number revealed loss of alleles 3 and 4. With these deletions characterized, the cell line was deemed acceptable for future experiments and for the remainder of the study will be referred to as PERKLOW.
Figure 2
CRISPR-mediated knockdown HEK293T cell line generation. (A) HEK293T subclones generated from PERK-specific sgRNA express a gene product at significantly lower abundances. (B) Expected editing sites in exon 5 of PERK with sequencing using MiSeq. Four significant alleles were identified, three of which led to early translation termination. All edits occurred as expected in relation to the 20 nt gRNA and PAM-recognition site, denoted in green and purple, respectively. Allelic frequencies are given for both low (p. 13) and high passage (p.108) variants. (C) Overall reducing potential of wild-type (WT) and PERKLOW cells was determined over a 72-h time course using an alamarBlue-based protocol. A slight but significant difference (~3%) was observed at 24 h. Statistical significance determined using multiple t-tests and a Holm–Sidak correction. ** p-value < 0.01
We assessed whether these PERKLOW cells had reduced viability by using a resazurin-based assay that measures reducing potential of cells in culture, a proxy for overall cell health. Measurements were made every 24 h for 72 h. PERKLOW cells did have a slight increase in viability at 24 h, but the effect was lost at later time points (Figure 2C). Although this effect was significant, it corresponded to a miniscule increase, therefore we did not assign importance to the effect.We then used these cells to interrogate what effect, if any, PERK had on the ability of LGTV to replicate. We infected either wild-type (WT) or PERKLOW HEK293T cells with LGTV at an MOI of 1. Cell supernatants and total RNA were collected at 24, 48, and 72 hpi. PERKLOW cells produced eight-fold higher titers of infectious virus compared to WT and continued this trend throughout the infection time course, consistent with the MBFVs (Figure 3A). These results are consistent with the previously described antiviral role of PERK in MBFV infection (WNV, DENV, WNVKUN [25,26,27]). We also measured intracellular LGTV genome abundance of (+) and (−) strands using qPCR. Copies of the positive sense, virion genome strand correlated with the infectious virus titer data, with PERKLOW cells harboring higher genome copies at all examined time points (Figure 3B). Copies of the negative-sense strand, an obligate intermediate of genomic replication, showed a similar trend (Figure 3C). The combined increase in infectious virus and genome production in PERKLOW cells implicate PERK as an antiviral factor in LGTV replication.
Figure 3
PERK has an antiviral effect on infectious LGTV release and genome replication. (A) PERKLOW HEK293T cells released higher infectious titers at all examined timepoints compared to WT HEK293T cells following infection at MOI = 1. (B) PERKLOW HEK293T cells produced higher quantities of (+) sense genomic LGTV RNA at all examined time points compared to WT HEK293T cells following LGTV infection at MOI = 1. (C) PERKLOW HEK 293T cells contained higher quantities of (-) sense genomic LGTV RNA at 48 and 72 hpi compared to WT HEK293T cells following LGTV infection at MOI = 1. No difference was observed at 24 hpi. (D) PERKLOW HEK293T cells had no significant difference in infectious virus release when compared to WT controls at 24 and 48 hpi. Lower titers were observed at 72 hpi when compared to WT HEK293T cells. Statistical significance determined using multiple t-tests and a Holm–Sidak correction. * p-value < 0.05; ** p-value < 0.01
Because LGTV is a naturally attenuated TBFV, we wanted to also assess the impact of PERK reduction on replication of a more pathogenic TBFV, POWV. In contrast to LGTV, no significant effect of PERK knockdown on POWV infectious virus titers was noted until 72 h, and at that time point output was reduced as compared to the WT cells (Figure 3D). These data suggest that POWV may have acquired a strategy to antagonize PERK-mediated restriction, although more experiments are required to confirm this result. Additionally of note, production of POWV was 10–100 times higher than that of LGTV.
3.4. PERK-Mediated CHOP Expression Is Important to Control LGTV Infection
We next assayed the impact of reduced expression of PERK on several UPR and autophagy components in both mock- and LGTV-infected cells. Basal levels of BiP were slightly higher in the PERKLOW cells, possibly reflecting a compensatory shift in UPR signaling, consequent to the reduction of PERK activity (Figure 4A). This effect has also been noted in PERK knockout mice [53]. Nevertheless, LGTV infection still dramatically induced expression, which was expected given the other sensors of the UPR were still functional. Interestingly, ATF6 activation was not increased despite the lack of PERK availability.
Figure 4
Reduced levels of PERK modify UPR and autophagy signaling during LGTV infection. (A) PERKLOW HEK293T cells express BiP highly throughout the infection time course. No observed ATF6 cleavage or CHOP induction. LGTV E increases over infection time course. (B) PERKLOW HEK293T cells have higher expression of LC3-I under basal conditions. Blocking autolysosomal degradation with BafA1 induced only slight increase in LC3-II showing inhibition of LC3 lipidation. Band intensity normalized to mock LC3 intensity and reported below bands. (C) PERKLOW HEK293T have increased total LC3 expression after 24 h LGTV infection when blocking degradation although almost entirely in unlipidated LC3-I form, indicating a block in LC3 processing. (D) Representative images of PERK knockdown cells treated with EBSS, BafA1, or LGTV infection. DAPI represented in blue, LC3 in green, and LGTV NS3 in red. Images acquired at 63x magnification. (E) Average autophagosomes per cell identified by LC3 fluorescent signal normalized to number of nuclei. Fewer autophagosomes identified in PERKLOW cells even following BafA1 treatment.
PERK is thought to phosphorylate eIF2α, thus attenuating translation during times of unfolded protein stress and leading to increased expression of CHOP. We consistently observed an almost complete ablation of CHOP expression in LGTV-infected PERKLOW cells (Figure 4A). This finding agrees with the current MBFV literature in that PERK signaling is responsible for the bulk of CHOP expression during infection.In addition to UPR elements, we also examined the autophagic state of the PERKLOW cells by examining LC3 levels. At a basal state, more LC3-I was present than LC3-II, indicating a potential inhibition of LC3 lipidation, similar to LGTV infection (Figure 4B). When treated with BafA1, a slight increase in LC3-II was observed, but the majority of expressed LC3 remained unlipidated. This trend remained consistent with EBSS starvation conditions. LGTV infection appeared to ablate LC3 lipidation in the PERKLOW cells, even with nutrient starvation (Figure 4C). We suspect this is a combinatorial effect of the lower lipidation observed under mock conditions in PERKLOW cells and in LGTV infection in WT cells.Again, we examined autophagic activity by IF, staining for LC3 (green) and LGTVNS3 (red). Greater band intensity compared to WT mock controls (Figure 1B) did not translate to higher autophagosome counts (Figure 4D,E). This is likely because the majority of signal observed in immunoblots is of the unlipidated LC3-I form, which is unable to insert into autophagosome membranes and does not aggregate into tight puncta [33]. When comparing EBSS starvation plus BafA1 treatments, the condition in which the highest number of autophagosomes are expected, we observed an approximately three-fold reduction when comparing the PERKLOW cells to WT controls. Taken together, these results reaffirm both the reported role of PERK in LC3 lipidation and the ability of LGTV to inhibit this process.
4. Discussion
Viruses must subtly coopt host metabolism to replicate successfully while simultaneously evading the host’s innate antiviral immune responses. Several viruses, including the flaviviruses, have evolved mechanisms to suppress host immune signaling [54,55]. However, certain intrinsic stress systems, such as the UPR, can be harder to circumvent since they do not directly sense the virus. The UPR detects and responds to unusually large quantities of unfolded protein within the ER lumen, as commonly occurs during viral replication. An activated UPR response can lead to deleterious effects for both the cell and the virus, and some of the impact is mediated via the PERK arm of the UPR. Activated PERK phosphorylates eIF2α, which rapidly inhibits protein synthesis, and can lead to CHOP-mediated apoptosis. PERK also engages the autophagic system via LC3 lipidation, a key element in autophagy [50,56]. PERK signaling has been demonstrated to inhibit several mosquito-borne flaviviruses, including DENV, WNV, and WNVKUN [25,26,27]. However, data regarding the role of PERK in TBFV expression is sparse.In this study, we demonstrated that LGTV infection induces robust UPR activation, as evidenced by the dramatic increase in BiP expression (Figure 1A). PERK remained constant throughout the course of infection, but the levels of CHOP increased, indicating UPR activation through the PERK arm (Figure 1A). Finally, LGTV infection induced changes in autophagic flux (Figure 1B,C). Despite an increase in total LC3 expression upon infection, the majority remained unlipidated and was unable to aggregate in autophagosome membranes suggesting the virus somehow inhibited LC3 processing limiting overall autophagic flux.We next showed that PERK has a clear effect on the LGTV lifecycle by infecting PERKLOW cells in which we had reduced PERK expression by CRISPR technology (Figure 2A). LGTV titers reached significantly higher levels in PERKLOW cells (Figure 3A). However, the same effect was not observed when examining POWVinfection. In fact, by 72 hpi, PERKLOW cells produced less infectious virus than WT controls (Figure 3D). A related TBFV, TBEV, also is reported to be unaffected by PERK depletion by shRNA [29]. These more pathogenic viruses may be able to better antagonize antiviral agents such as PERK. Even though no difference in growth kinetics was observed between WT and PERKLOW cells at 24 hpi, both cell lines produced nearly 100-fold higher levels of infectious virus when compared to LGTV-infected counterparts. This difference in growth kinetics poses an interesting question for future inquiries and may be responsible for the more detrimental nature of POWVinfection.To determine why virus titers were higher in the PERKLOW cells, we reexamined UPR and autophagy targets by western blot. BiP expression was higher in PERKLOW cells, a finding we interpreted to reflect a compensatory shift in UPR signaling, consistent with previous literature. In addition, CHOP levels were much higher in infected WT cells than in PERKLOW counterparts. A number of other kinases can phosphorylate eIF2α in cell stress conditions and lead to CHOP induction [57], PKR [58], heme-regulated eIF2α kinase (HRI) [59], and general control nonderepressible 2 (GCN2) [60]. We speculate that LGTV may be able to antagonize some paths of eIF2α phosphorylation, but not that of PERK. PKR is a well-characterized sensor of dsRNA, a viral replicative intermediate, and previous studies have described flaviviral inhibition or evasion of PKR-mediated eIF2α phosphorylation [61,62]. It is plausible that the direct interaction between viral dsRNA and PKR forced an evolutionary response from the virus much more robustly than the interaction between viral elements and PERK. We are currently identifying strategies to further explore this complex interplay. Differences in autophagic activity were also observed in PERKLOW cells. A decrease in both LC3-II abundance by immunoblot and in autophagosome formation by IF suggest that PERK plays some role in LC3 lipidation and processing. However, similar trends in autophagic activity were seen when comparing WT and PERKLOW cells infected with LGTV, suggesting decreased autophagic flux is not necessarily the cause of decreased infectious output, although further experiments are necessary to confirm.The mechanisms explaining how different flaviviruses alter host cell programs in order to fine tune metabolism for optimal replication remain largely unknown. While this study and others increase our understanding of how these agents operate, they are restricted to single cell types and viruses. Put differently, each virus appears to possess its own mechanism, distinctive not only among related viruses, but among various cell types as well. Global techniques spanning tissues of both mammal and arthropod vectors [63] will be invaluable in unraveling the biology of these pathogens, and eventually devising ways to combat them.
Authors: Sonja M Best; Keely L Morris; Jeffrey G Shannon; Shelly J Robertson; Dana N Mitzel; Gregory S Park; Elena Boer; James B Wolfinbarger; Marshall E Bloom Journal: J Virol Date: 2005-10 Impact factor: 5.103
Authors: Alan P Dupuis; Ryan J Peters; Melissa A Prusinski; Richard C Falco; Richard S Ostfeld; Laura D Kramer Journal: Parasit Vectors Date: 2013-07-15 Impact factor: 3.876
Authors: Daniel J Klionsky; Kotb Abdelmohsen; Akihisa Abe; Md Joynal Abedin; Hagai Abeliovich; Abraham Acevedo Arozena; Hiroaki Adachi; Christopher M Adams; Peter D Adams; Khosrow Adeli; Peter J Adhihetty; Sharon G Adler; Galila Agam; Rajesh Agarwal; Manish K Aghi; Maria Agnello; Patrizia Agostinis; Patricia V Aguilar; Julio Aguirre-Ghiso; Edoardo M Airoldi; Slimane Ait-Si-Ali; Takahiko Akematsu; Emmanuel T Akporiaye; Mohamed Al-Rubeai; Guillermo M Albaiceta; Chris Albanese; Diego Albani; Matthew L Albert; Jesus Aldudo; Hana Algül; Mehrdad Alirezaei; Iraide Alloza; Alexandru Almasan; Maylin Almonte-Beceril; Emad S Alnemri; Covadonga Alonso; Nihal Altan-Bonnet; Dario C Altieri; Silvia Alvarez; Lydia Alvarez-Erviti; Sandro Alves; Giuseppina Amadoro; Atsuo Amano; Consuelo Amantini; Santiago Ambrosio; Ivano Amelio; Amal O Amer; Mohamed Amessou; Angelika Amon; Zhenyi An; Frank A Anania; Stig U Andersen; Usha P Andley; Catherine K Andreadi; Nathalie Andrieu-Abadie; Alberto Anel; David K Ann; Shailendra Anoopkumar-Dukie; Manuela Antonioli; Hiroshi Aoki; Nadezda Apostolova; Saveria Aquila; Katia Aquilano; Koichi Araki; Eli Arama; Agustin Aranda; Jun Araya; Alexandre Arcaro; Esperanza Arias; Hirokazu Arimoto; Aileen R Ariosa; Jane L Armstrong; Thierry Arnould; Ivica Arsov; Katsuhiko Asanuma; Valerie Askanas; Eric Asselin; Ryuichiro Atarashi; Sally S Atherton; Julie D Atkin; Laura D Attardi; Patrick Auberger; Georg Auburger; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Maria Laura Avantaggiati; Limor Avrahami; Suresh Awale; Neelam Azad; Tiziana Bachetti; Jonathan M Backer; Dong-Hun Bae; Jae-Sung Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Seung-Hoon Baek; Stephen Baghdiguian; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xue-Yuan Bai; Yannick Bailly; Kithiganahalli Narayanaswamy Balaji; Walter Balduini; Andrea Ballabio; Rena Balzan; Rajkumar Banerjee; Gábor Bánhegyi; Haijun Bao; Benoit Barbeau; Maria D Barrachina; Esther Barreiro; Bonnie Bartel; Alberto Bartolomé; Diane C Bassham; Maria Teresa Bassi; Robert C Bast; Alakananda Basu; Maria Teresa Batista; Henri Batoko; Maurizio Battino; Kyle Bauckman; Bradley L Baumgarner; K Ulrich Bayer; Rupert Beale; Jean-François Beaulieu; George R Beck; Christoph Becker; J David Beckham; Pierre-André Bédard; Patrick J Bednarski; Thomas J Begley; Christian Behl; Christian Behrends; Georg Mn Behrens; Kevin E Behrns; Eloy Bejarano; Amine Belaid; Francesca Belleudi; Giovanni Bénard; Guy Berchem; Daniele Bergamaschi; Matteo Bergami; Ben Berkhout; Laura Berliocchi; Amélie Bernard; Monique Bernard; Francesca Bernassola; Anne Bertolotti; Amanda S Bess; Sébastien Besteiro; Saverio Bettuzzi; Savita Bhalla; Shalmoli Bhattacharyya; Sujit K Bhutia; Caroline Biagosch; Michele Wolfe Bianchi; Martine Biard-Piechaczyk; Viktor Billes; Claudia Bincoletto; Baris Bingol; Sara W Bird; Marc Bitoun; Ivana Bjedov; Craig Blackstone; Lionel Blanc; Guillermo A Blanco; Heidi Kiil Blomhoff; Emilio Boada-Romero; Stefan Böckler; Marianne Boes; Kathleen Boesze-Battaglia; Lawrence H Boise; Alessandra Bolino; Andrea Boman; Paolo Bonaldo; Matteo Bordi; Jürgen Bosch; Luis M Botana; Joelle Botti; German Bou; Marina Bouché; Marion Bouchecareilh; Marie-Josée Boucher; Michael E Boulton; Sebastien G Bouret; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan Brady; Vania Mm Braga; Claudio Brancolini; Gerhard H Braus; José M Bravo-San Pedro; Lisa A Brennan; Emery H Bresnick; Patrick Brest; Dave Bridges; Marie-Agnès Bringer; Marisa Brini; Glauber C Brito; Bertha Brodin; Paul S Brookes; Eric J Brown; Karen Brown; Hal E Broxmeyer; Alain Bruhat; Patricia Chakur Brum; John H Brumell; Nicola Brunetti-Pierri; Robert J Bryson-Richardson; Shilpa Buch; Alastair M Buchan; Hikmet Budak; Dmitry V Bulavin; Scott J Bultman; Geert Bultynck; Vladimir Bumbasirevic; Yan Burelle; Robert E Burke; Margit Burmeister; Peter Bütikofer; Laura Caberlotto; Ken Cadwell; Monika Cahova; Dongsheng Cai; Jingjing Cai; Qian Cai; Sara Calatayud; Nadine Camougrand; Michelangelo Campanella; Grant R Campbell; Matthew Campbell; Silvia Campello; Robin Candau; Isabella Caniggia; Lavinia Cantoni; Lizhi Cao; Allan B Caplan; Michele Caraglia; Claudio Cardinali; Sandra Morais Cardoso; Jennifer S Carew; Laura A Carleton; Cathleen R Carlin; Silvia Carloni; Sven R Carlsson; Didac Carmona-Gutierrez; Leticia Am Carneiro; Oliana Carnevali; Serena Carra; Alice Carrier; Bernadette Carroll; Caty Casas; Josefina Casas; Giuliana Cassinelli; Perrine Castets; Susana Castro-Obregon; Gabriella Cavallini; Isabella Ceccherini; Francesco Cecconi; Arthur I Cederbaum; Valentín Ceña; Simone Cenci; Claudia Cerella; Davide Cervia; Silvia Cetrullo; Hassan Chaachouay; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Georgios Chamilos; Edmond Yw Chan; Matthew Tv Chan; Dhyan Chandra; Pallavi Chandra; Chih-Peng Chang; Raymond Chuen-Chung Chang; Ta Yuan Chang; John C Chatham; Saurabh Chatterjee; Santosh Chauhan; Yongsheng Che; Michael E Cheetham; Rajkumar Cheluvappa; Chun-Jung Chen; Gang Chen; Guang-Chao Chen; Guoqiang Chen; Hongzhuan Chen; Jeff W Chen; Jian-Kang Chen; Min Chen; Mingzhou Chen; Peiwen Chen; Qi Chen; Quan Chen; Shang-Der Chen; Si Chen; Steve S-L Chen; Wei Chen; Wei-Jung Chen; Wen Qiang Chen; Wenli Chen; Xiangmei Chen; Yau-Hung Chen; Ye-Guang Chen; Yin Chen; Yingyu Chen; Yongshun Chen; Yu-Jen Chen; Yue-Qin Chen; Yujie Chen; Zhen Chen; Zhong Chen; Alan Cheng; Christopher Hk Cheng; Hua Cheng; Heesun Cheong; Sara Cherry; Jason Chesney; Chun Hei Antonio Cheung; Eric Chevet; Hsiang Cheng Chi; Sung-Gil Chi; Fulvio Chiacchiera; Hui-Ling Chiang; Roberto Chiarelli; Mario Chiariello; Marcello Chieppa; Lih-Shen Chin; Mario Chiong; Gigi Nc Chiu; Dong-Hyung Cho; Ssang-Goo Cho; William C Cho; Yong-Yeon Cho; Young-Seok Cho; Augustine Mk Choi; Eui-Ju Choi; Eun-Kyoung Choi; Jayoung Choi; Mary E Choi; Seung-Il Choi; Tsui-Fen Chou; Salem Chouaib; Divaker Choubey; Vinay Choubey; Kuan-Chih Chow; Kamal Chowdhury; Charleen T Chu; Tsung-Hsien Chuang; Taehoon Chun; Hyewon Chung; Taijoon Chung; Yuen-Li Chung; Yong-Joon Chwae; Valentina Cianfanelli; Roberto Ciarcia; Iwona A Ciechomska; Maria Rosa Ciriolo; Mara Cirone; Sofie Claerhout; Michael J Clague; Joan Clària; Peter Gh Clarke; Robert Clarke; Emilio Clementi; Cédric Cleyrat; Miriam Cnop; Eliana M Coccia; Tiziana Cocco; Patrice Codogno; Jörn Coers; Ezra Ew Cohen; David Colecchia; Luisa Coletto; Núria S Coll; Emma Colucci-Guyon; Sergio Comincini; Maria Condello; Katherine L Cook; Graham H Coombs; Cynthia D Cooper; J Mark Cooper; Isabelle Coppens; Maria Tiziana Corasaniti; Marco Corazzari; Ramon Corbalan; Elisabeth Corcelle-Termeau; Mario D Cordero; Cristina Corral-Ramos; Olga Corti; Andrea Cossarizza; Paola Costelli; Safia Costes; Susan L Cotman; Ana Coto-Montes; Sandra Cottet; Eduardo Couve; Lori R Covey; L Ashley Cowart; Jeffery S Cox; Fraser P Coxon; Carolyn B Coyne; Mark S Cragg; Rolf J Craven; Tiziana Crepaldi; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Maria Teresa Cruz; Ana Maria Cuervo; Jose M Cuezva; Taixing Cui; Pedro R Cutillas; Mark J Czaja; Maria F Czyzyk-Krzeska; Ruben K Dagda; Uta Dahmen; Chunsun Dai; Wenjie Dai; Yun Dai; Kevin N Dalby; Luisa Dalla Valle; Guillaume Dalmasso; Marcello D'Amelio; Markus Damme; Arlette Darfeuille-Michaud; Catherine Dargemont; Victor M Darley-Usmar; Srinivasan Dasarathy; Biplab Dasgupta; Srikanta Dash; Crispin R Dass; Hazel Marie Davey; Lester M Davids; David Dávila; Roger J Davis; Ted M Dawson; Valina L Dawson; Paula Daza; Jackie de Belleroche; Paul de Figueiredo; Regina Celia Bressan Queiroz de Figueiredo; José de la Fuente; Luisa De Martino; Antonella De Matteis; Guido Ry De Meyer; Angelo De Milito; Mauro De Santi; Wanderley de Souza; Vincenzo De Tata; Daniela De Zio; Jayanta Debnath; Reinhard Dechant; Jean-Paul Decuypere; Shane Deegan; Benjamin Dehay; Barbara Del Bello; Dominic P Del Re; Régis Delage-Mourroux; Lea Md Delbridge; Louise Deldicque; Elizabeth Delorme-Axford; Yizhen Deng; Joern Dengjel; Melanie Denizot; Paul Dent; Channing J Der; Vojo Deretic; Benoît Derrien; Eric Deutsch; Timothy P Devarenne; Rodney J Devenish; Sabrina Di Bartolomeo; Nicola Di Daniele; Fabio Di Domenico; Alessia Di Nardo; Simone Di Paola; Antonio Di Pietro; Livia Di Renzo; Aaron DiAntonio; Guillermo Díaz-Araya; Ines Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Chad A Dickey; Robert C Dickson; Marc Diederich; Paul Digard; Ivan Dikic; Savithrama P Dinesh-Kumar; Chan Ding; Wen-Xing Ding; Zufeng Ding; Luciana Dini; Jörg Hw Distler; Abhinav Diwan; Mojgan Djavaheri-Mergny; Kostyantyn Dmytruk; Renwick Cj Dobson; Volker Doetsch; Karol Dokladny; Svetlana Dokudovskaya; Massimo Donadelli; X Charlie Dong; Xiaonan Dong; Zheng Dong; Terrence M Donohue; Kelly S Doran; Gabriella D'Orazi; Gerald W Dorn; Victor Dosenko; Sami Dridi; Liat Drucker; Jie Du; Li-Lin Du; Lihuan Du; André du Toit; Priyamvada Dua; Lei Duan; Pu Duann; Vikash Kumar Dubey; Michael R Duchen; Michel A Duchosal; Helene Duez; Isabelle Dugail; Verónica I Dumit; Mara C Duncan; Elaine A Dunlop; William A Dunn; Nicolas Dupont; Luc Dupuis; Raúl V Durán; Thomas M Durcan; Stéphane Duvezin-Caubet; Umamaheswar Duvvuri; Vinay Eapen; Darius Ebrahimi-Fakhari; Arnaud Echard; Leopold Eckhart; Charles L Edelstein; Aimee L Edinger; Ludwig Eichinger; Tobias Eisenberg; Avital Eisenberg-Lerner; N Tony Eissa; Wafik S El-Deiry; Victoria El-Khoury; Zvulun Elazar; Hagit Eldar-Finkelman; Chris Jh Elliott; Enzo Emanuele; Urban Emmenegger; Nikolai Engedal; Anna-Mart Engelbrecht; Simone Engelender; Jorrit M Enserink; Ralf Erdmann; Jekaterina Erenpreisa; Rajaraman Eri; Jason L Eriksen; Andreja Erman; Ricardo Escalante; Eeva-Liisa Eskelinen; Lucile Espert; Lorena Esteban-Martínez; Thomas J Evans; Mario Fabri; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Nils J Færgeman; Alberto Faggioni; W Douglas Fairlie; Chunhai Fan; Daping Fan; Jie Fan; Shengyun Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Mathias Faure; Francois B Favier; Howard Fearnhead; Massimo Federici; Erkang Fei; Tania C Felizardo; Hua Feng; Yibin Feng; Yuchen Feng; Thomas A Ferguson; Álvaro F Fernández; Maite G Fernandez-Barrena; Jose C Fernandez-Checa; Arsenio Fernández-López; Martin E Fernandez-Zapico; Olivier Feron; Elisabetta Ferraro; Carmen Veríssima Ferreira-Halder; Laszlo Fesus; Ralph Feuer; Fabienne C Fiesel; Eduardo C Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; John H Fingert; Steven Finkbeiner; Toren Finkel; Filomena Fiorito; Paul B Fisher; Marc Flajolet; Flavio Flamigni; Oliver Florey; Salvatore Florio; R Andres Floto; Marco Folini; Carlo Follo; Edward A Fon; Francesco Fornai; Franco Fortunato; Alessandro Fraldi; Rodrigo Franco; Arnaud Francois; Aurélie François; Lisa B Frankel; Iain Dc Fraser; Norbert Frey; Damien G Freyssenet; Christian Frezza; Scott L Friedman; Daniel E Frigo; Dongxu Fu; José M Fuentes; Juan Fueyo; Yoshio Fujitani; Yuuki Fujiwara; Mikihiro Fujiya; Mitsunori Fukuda; Simone Fulda; Carmela Fusco; Bozena Gabryel; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Sehamuddin Galadari; Gad Galili; Inmaculada Galindo; Maria F Galindo; Giovanna Galliciotti; Lorenzo Galluzzi; Luca Galluzzi; Vincent Galy; Noor Gammoh; Sam Gandy; Anand K Ganesan; Swamynathan Ganesan; Ian G Ganley; Monique Gannagé; Fen-Biao Gao; Feng Gao; Jian-Xin Gao; Lorena García Nannig; Eleonora García Véscovi; Marina Garcia-Macía; Carmen Garcia-Ruiz; Abhishek D Garg; Pramod Kumar Garg; Ricardo Gargini; Nils Christian Gassen; Damián Gatica; Evelina Gatti; Julie Gavard; Evripidis Gavathiotis; Liang Ge; Pengfei Ge; Shengfang Ge; Po-Wu Gean; Vania Gelmetti; Armando A Genazzani; Jiefei Geng; Pascal Genschik; Lisa Gerner; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Eric Ghigo; Debabrata Ghosh; Anna Maria Giammarioli; Francesca Giampieri; Claudia Giampietri; Alexandra Giatromanolaki; Derrick J Gibbings; Lara Gibellini; Spencer B Gibson; Vanessa Ginet; Antonio Giordano; Flaviano Giorgini; Elisa Giovannetti; Stephen E Girardin; Suzana Gispert; Sandy Giuliano; Candece L Gladson; Alvaro Glavic; Martin Gleave; Nelly Godefroy; Robert M Gogal; Kuppan Gokulan; Gustavo H Goldman; Delia Goletti; Michael S Goligorsky; Aldrin V Gomes; Ligia C Gomes; Hernando Gomez; Candelaria Gomez-Manzano; Rubén Gómez-Sánchez; Dawit Ap Gonçalves; Ebru Goncu; Qingqiu Gong; Céline Gongora; Carlos B Gonzalez; Pedro Gonzalez-Alegre; Pilar Gonzalez-Cabo; Rosa Ana González-Polo; Ing Swie Goping; Carlos Gorbea; Nikolai V Gorbunov; Daphne R Goring; Adrienne M Gorman; Sharon M Gorski; Sandro Goruppi; Shino Goto-Yamada; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Yacine Graba; Martin Graef; Giovanna E Granato; Gary Dean Grant; Steven Grant; Giovanni Luca Gravina; Douglas R Green; Alexander Greenhough; Michael T Greenwood; Benedetto Grimaldi; Frédéric Gros; Charles Grose; Jean-Francois Groulx; Florian Gruber; Paolo Grumati; Tilman Grune; Jun-Lin Guan; Kun-Liang Guan; Barbara Guerra; Carlos Guillen; Kailash Gulshan; Jan Gunst; Chuanyong Guo; Lei Guo; Ming Guo; Wenjie Guo; Xu-Guang Guo; Andrea A Gust; Åsa B Gustafsson; Elaine Gutierrez; Maximiliano G Gutierrez; Ho-Shin Gwak; Albert Haas; James E Haber; Shinji Hadano; Monica Hagedorn; David R Hahn; Andrew J Halayko; Anne Hamacher-Brady; Kozo Hamada; Ahmed Hamai; Andrea Hamann; Maho Hamasaki; Isabelle Hamer; Qutayba Hamid; Ester M Hammond; Feng Han; Weidong Han; James T Handa; John A Hanover; Malene Hansen; Masaru Harada; Ljubica Harhaji-Trajkovic; J Wade Harper; Abdel Halim Harrath; Adrian L Harris; James Harris; Udo Hasler; Peter Hasselblatt; Kazuhisa Hasui; Robert G Hawley; Teresa S Hawley; Congcong He; Cynthia Y He; Fengtian He; Gu He; Rong-Rong He; Xian-Hui He; You-Wen He; Yu-Ying He; Joan K Heath; Marie-Josée Hébert; Robert A Heinzen; Gudmundur Vignir Helgason; Michael Hensel; Elizabeth P Henske; Chengtao Her; Paul K Herman; Agustín Hernández; Carlos Hernandez; Sonia Hernández-Tiedra; Claudio Hetz; P Robin Hiesinger; Katsumi Higaki; Sabine Hilfiker; Bradford G Hill; Joseph A Hill; William D Hill; Keisuke Hino; Daniel Hofius; Paul Hofman; Günter U Höglinger; Jörg Höhfeld; Marina K Holz; Yonggeun Hong; David A Hood; Jeroen Jm Hoozemans; Thorsten Hoppe; Chin Hsu; Chin-Yuan Hsu; Li-Chung Hsu; Dong Hu; Guochang Hu; Hong-Ming Hu; Hongbo Hu; Ming Chang Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Ya Hua; Canhua Huang; Huey-Lan Huang; Kuo-How Huang; Kuo-Yang Huang; Shile Huang; Shiqian Huang; Wei-Pang Huang; Yi-Ran Huang; Yong Huang; Yunfei Huang; Tobias B Huber; Patricia Huebbe; Won-Ki Huh; Juha J Hulmi; Gang Min Hur; James H Hurley; Zvenyslava Husak; Sabah Na Hussain; Salik Hussain; Jung Jin Hwang; Seungmin Hwang; Thomas Is Hwang; Atsuhiro Ichihara; Yuzuru Imai; Carol Imbriano; Megumi Inomata; Takeshi Into; Valentina Iovane; Juan L Iovanna; Renato V Iozzo; Nancy Y Ip; Javier E Irazoqui; Pablo Iribarren; Yoshitaka Isaka; Aleksandra J Isakovic; Harry Ischiropoulos; Jeffrey S Isenberg; Mohammad Ishaq; Hiroyuki Ishida; Isao Ishii; Jane E Ishmael; Ciro Isidoro; Ken-Ichi Isobe; Erika Isono; Shohreh Issazadeh-Navikas; Koji Itahana; Eisuke Itakura; Andrei I Ivanov; Anand Krishnan V Iyer; José M Izquierdo; Yotaro Izumi; Valentina Izzo; Marja Jäättelä; Nadia Jaber; Daniel John Jackson; William T Jackson; Tony George Jacob; Thomas S Jacques; Chinnaswamy Jagannath; Ashish Jain; Nihar Ranjan Jana; Byoung Kuk Jang; Alkesh Jani; Bassam Janji; Paulo Roberto Jannig; Patric J Jansson; Steve Jean; Marina Jendrach; Ju-Hong Jeon; Niels Jessen; Eui-Bae Jeung; Kailiang Jia; Lijun Jia; Hong Jiang; Hongchi Jiang; Liwen Jiang; Teng Jiang; Xiaoyan Jiang; Xuejun Jiang; Xuejun Jiang; Ying Jiang; Yongjun Jiang; Alberto Jiménez; Cheng Jin; Hongchuan Jin; Lei Jin; Meiyan Jin; Shengkan Jin; Umesh Kumar Jinwal; Eun-Kyeong Jo; Terje Johansen; Daniel E Johnson; Gail Vw Johnson; James D Johnson; Eric Jonasch; Chris Jones; Leo Ab Joosten; Joaquin Jordan; Anna-Maria Joseph; Bertrand Joseph; Annie M Joubert; Dianwen Ju; Jingfang Ju; Hsueh-Fen Juan; Katrin Juenemann; Gábor Juhász; Hye Seung Jung; Jae U Jung; Yong-Keun Jung; Heinz Jungbluth; Matthew J Justice; Barry Jutten; Nadeem O Kaakoush; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Bertrand Kaeffer; Katarina Kågedal; Alon Kahana; Shingo Kajimura; Or Kakhlon; Manjula Kalia; Dhan V Kalvakolanu; Yoshiaki Kamada; Konstantinos Kambas; Vitaliy O Kaminskyy; Harm H Kampinga; Mustapha Kandouz; Chanhee Kang; Rui Kang; Tae-Cheon Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Marc Kantorow; Maria Kaparakis-Liaskos; Orsolya Kapuy; Vassiliki Karantza; Md Razaul Karim; Parimal Karmakar; Arthur Kaser; Susmita Kaushik; Thomas Kawula; A Murat Kaynar; Po-Yuan Ke; Zun-Ji Ke; John H Kehrl; Kate E Keller; Jongsook Kim Kemper; Anne K Kenworthy; Oliver Kepp; Andreas Kern; Santosh Kesari; David Kessel; Robin Ketteler; Isis do Carmo Kettelhut; Bilon Khambu; Muzamil Majid Khan; Vinoth Km Khandelwal; Sangeeta Khare; Juliann G Kiang; Amy A Kiger; Akio Kihara; Arianna L Kim; Cheol Hyeon Kim; Deok Ryong Kim; Do-Hyung Kim; Eung Kweon Kim; Hye Young Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; Jin Hyoung Kim; Kwang Woon Kim; Michael D Kim; Moon-Moo Kim; Peter K Kim; Seong Who Kim; Soo-Youl Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Jason S King; Karla Kirkegaard; Vladimir Kirkin; Lorrie A Kirshenbaum; Shuji Kishi; Yasuo Kitajima; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Rudolf A Kley; Walter T Klimecki; Michael Klinkenberg; Jochen Klucken; Helene Knævelsrud; Erwin Knecht; Laura Knuppertz; Jiunn-Liang Ko; Satoru Kobayashi; Jan C Koch; Christelle Koechlin-Ramonatxo; Ulrich Koenig; Young Ho Koh; Katja Köhler; Sepp D Kohlwein; Masato Koike; Masaaki Komatsu; Eiki Kominami; Dexin Kong; Hee Jeong Kong; Eumorphia G Konstantakou; Benjamin T Kopp; Tamas Korcsmaros; Laura Korhonen; Viktor I Korolchuk; Nadya V Koshkina; Yanjun Kou; Michael I Koukourakis; Constantinos Koumenis; Attila L Kovács; Tibor Kovács; Werner J Kovacs; Daisuke Koya; Claudine Kraft; Dimitri Krainc; Helmut Kramer; Tamara Kravic-Stevovic; Wilhelm Krek; Carole Kretz-Remy; Roswitha Krick; Malathi Krishnamurthy; Janos Kriston-Vizi; Guido Kroemer; Michael C Kruer; Rejko Kruger; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Christian Kuhn; Addanki Pratap Kumar; Anuj Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Rakesh Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Atsushi Kuno; Sheng-Han Kuo; Jeff Kuret; Tino Kurz; Terry Kwok; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert R La Spada; Frank Lafont; Tim Lahm; Aparna Lakkaraju; Truong Lam; Trond Lamark; Steve Lancel; Terry H Landowski; Darius J R Lane; Jon D Lane; Cinzia Lanzi; Pierre Lapaquette; Louis R Lapierre; Jocelyn Laporte; Johanna Laukkarinen; Gordon W Laurie; Sergio Lavandero; Lena Lavie; Matthew J LaVoie; Betty Yuen Kwan Law; Helen Ka-Wai Law; Kelsey B Law; Robert Layfield; Pedro A Lazo; Laurent Le Cam; Karine G Le Roch; Hervé Le Stunff; Vijittra Leardkamolkarn; Marc Lecuit; Byung-Hoon Lee; Che-Hsin Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Hsinyu Lee; Jae Keun Lee; Jongdae Lee; Ju-Hyun Lee; Jun Hee Lee; Michael Lee; Myung-Shik Lee; Patty J Lee; Sam W Lee; Seung-Jae Lee; Shiow-Ju Lee; Stella Y Lee; Sug Hyung Lee; Sung Sik Lee; Sung-Joon Lee; Sunhee Lee; Ying-Ray Lee; Yong J Lee; Young H Lee; Christiaan Leeuwenburgh; Sylvain Lefort; Renaud Legouis; Jinzhi Lei; Qun-Ying Lei; David A Leib; Gil Leibowitz; Istvan Lekli; Stéphane D Lemaire; John J Lemasters; Marius K Lemberg; Antoinette Lemoine; Shuilong Leng; Guido Lenz; Paola Lenzi; Lilach O Lerman; Daniele Lettieri Barbato; Julia I-Ju Leu; Hing Y Leung; Beth Levine; Patrick A Lewis; Frank Lezoualc'h; Chi Li; Faqiang Li; Feng-Jun Li; Jun Li; Ke Li; Lian Li; Min Li; Min Li; Qiang Li; Rui Li; Sheng Li; Wei Li; Wei Li; Xiaotao Li; Yumin Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Yulin Liao; Joana Liberal; Pawel P Liberski; Pearl Lie; Andrew P Lieberman; Hyunjung Jade Lim; Kah-Leong Lim; Kyu Lim; Raquel T Lima; Chang-Shen Lin; Chiou-Feng Lin; Fang Lin; Fangming Lin; Fu-Cheng Lin; Kui Lin; Kwang-Huei Lin; Pei-Hui Lin; Tianwei Lin; Wan-Wan Lin; Yee-Shin Lin; Yong Lin; Rafael Linden; Dan Lindholm; Lisa M Lindqvist; Paul Lingor; Andreas Linkermann; Lance A Liotta; Marta M Lipinski; Vitor A Lira; Michael P Lisanti; Paloma B Liton; Bo Liu; Chong Liu; Chun-Feng Liu; Fei Liu; Hung-Jen Liu; Jianxun Liu; Jing-Jing Liu; Jing-Lan Liu; Ke Liu; Leyuan Liu; Liang Liu; Quentin Liu; Rong-Yu Liu; Shiming Liu; Shuwen Liu; Wei Liu; Xian-De Liu; Xiangguo Liu; Xiao-Hong Liu; Xinfeng Liu; Xu Liu; Xueqin Liu; Yang Liu; Yule Liu; Zexian Liu; Zhe Liu; Juan P Liuzzi; Gérard Lizard; Mila Ljujic; Irfan J Lodhi; Susan E Logue; Bal L Lokeshwar; Yun Chau Long; Sagar Lonial; Benjamin Loos; Carlos López-Otín; Cristina López-Vicario; Mar Lorente; Philip L Lorenzi; Péter Lõrincz; Marek Los; Michael T Lotze; Penny E Lovat; Binfeng Lu; Bo Lu; Jiahong Lu; Qing Lu; She-Min Lu; Shuyan Lu; Yingying Lu; Frédéric Luciano; Shirley Luckhart; John Milton Lucocq; Paula Ludovico; Aurelia Lugea; Nicholas W Lukacs; Julian J Lum; Anders H Lund; Honglin Luo; Jia Luo; Shouqing Luo; Claudio Luparello; Timothy Lyons; Jianjie Ma; Yi Ma; Yong Ma; Zhenyi Ma; Juliano Machado; Glaucia M Machado-Santelli; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; John D MacMicking; Lee Ann MacMillan-Crow; Frank Madeo; Muniswamy Madesh; Julio Madrigal-Matute; Akiko Maeda; Tatsuya Maeda; Gustavo Maegawa; Emilia Maellaro; Hannelore Maes; Marta Magariños; Kenneth Maiese; Tapas K Maiti; Luigi Maiuri; Maria Chiara Maiuri; Carl G Maki; Roland Malli; Walter Malorni; Alina Maloyan; Fathia Mami-Chouaib; Na Man; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Serge N Manié; Claudia Manzoni; Kai Mao; Zixu Mao; Zong-Wan Mao; Philippe Marambaud; Anna Maria Marconi; Zvonimir Marelja; Gabriella Marfe; Marta Margeta; Eva Margittai; Muriel Mari; Francesca V Mariani; Concepcio Marin; Sara Marinelli; Guillermo Mariño; Ivanka Markovic; Rebecca Marquez; Alberto M Martelli; Sascha Martens; Katie R Martin; Seamus J Martin; Shaun Martin; Miguel A Martin-Acebes; Paloma Martín-Sanz; Camille Martinand-Mari; Wim Martinet; Jennifer Martinez; Nuria Martinez-Lopez; Ubaldo Martinez-Outschoorn; Moisés Martínez-Velázquez; Marta Martinez-Vicente; Waleska Kerllen Martins; Hirosato Mashima; James A Mastrianni; Giuseppe Matarese; Paola Matarrese; Roberto Mateo; Satoaki Matoba; Naomichi Matsumoto; Takehiko Matsushita; Akira Matsuura; Takeshi Matsuzawa; Mark P Mattson; Soledad Matus; Norma Maugeri; Caroline Mauvezin; Andreas Mayer; Dusica Maysinger; Guillermo D Mazzolini; Mary Kate McBrayer; Kimberly McCall; Craig McCormick; Gerald M McInerney; Skye C McIver; Sharon McKenna; John J McMahon; Iain A McNeish; Fatima Mechta-Grigoriou; Jan Paul Medema; Diego L Medina; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Yide Mei; Ute-Christiane Meier; Alfred J Meijer; Alicia Meléndez; Gerry Melino; Sonia Melino; Edesio Jose Tenorio de Melo; Maria A Mena; Marc D Meneghini; Javier A Menendez; Regina Menezes; Liesu Meng; Ling-Hua Meng; Songshu Meng; Rossella Menghini; A Sue Menko; Rubem Fs Menna-Barreto; Manoj B Menon; Marco A Meraz-Ríos; Giuseppe Merla; Luciano Merlini; Angelica M Merlot; Andreas Meryk; Stefania Meschini; Joel N Meyer; Man-Tian Mi; Chao-Yu Miao; Lucia Micale; Simon Michaeli; Carine Michiels; Anna Rita Migliaccio; Anastasia Susie Mihailidou; Dalibor Mijaljica; Katsuhiko Mikoshiba; Enrico Milan; Leonor Miller-Fleming; Gordon B Mills; Ian G Mills; Georgia Minakaki; Berge A Minassian; Xiu-Fen Ming; Farida Minibayeva; Elena A Minina; Justine D Mintern; Saverio Minucci; Antonio Miranda-Vizuete; Claire H Mitchell; Shigeki Miyamoto; Keisuke Miyazawa; Noboru Mizushima; Katarzyna Mnich; Baharia Mograbi; Simin Mohseni; Luis Ferreira Moita; Marco Molinari; Maurizio Molinari; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Marco Mongillo; Martha M Monick; Serena Montagnaro; Craig Montell; Darren J Moore; Michael N Moore; Rodrigo Mora-Rodriguez; Paula I Moreira; Etienne Morel; Maria Beatrice Morelli; Sandra Moreno; Michael J Morgan; Arnaud Moris; Yuji Moriyasu; Janna L Morrison; Lynda A Morrison; Eugenia Morselli; Jorge Moscat; Pope L Moseley; Serge Mostowy; Elisa Motori; Denis Mottet; Jeremy C Mottram; Charbel E-H Moussa; Vassiliki E Mpakou; Hasan Mukhtar; Jean M Mulcahy Levy; Sylviane Muller; Raquel Muñoz-Moreno; Cristina Muñoz-Pinedo; Christian Münz; Maureen E Murphy; James T Murray; Aditya Murthy; Indira U Mysorekar; Ivan R Nabi; Massimo Nabissi; Gustavo A Nader; Yukitoshi Nagahara; Yoshitaka Nagai; Kazuhiro Nagata; Anika Nagelkerke; Péter Nagy; Samisubbu R Naidu; Sreejayan Nair; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Gennaro Napolitano; Naweed I Naqvi; Roberta Nardacci; Derek P Narendra; Masashi Narita; Anna Chiara Nascimbeni; Ramesh Natarajan; Luiz C Navegantes; Steffan T Nawrocki; Taras Y Nazarko; Volodymyr Y Nazarko; Thomas Neill; Luca M Neri; Mihai G Netea; Romana T Netea-Maier; Bruno M Neves; Paul A Ney; Ioannis P Nezis; Hang Tt Nguyen; Huu Phuc Nguyen; Anne-Sophie Nicot; Hilde Nilsen; Per Nilsson; Mikio Nishimura; Ichizo Nishino; Mireia Niso-Santano; Hua Niu; Ralph A Nixon; Vincent Co Njar; Takeshi Noda; Angelika A Noegel; Elsie Magdalena Nolte; Erik Norberg; Koenraad K Norga; Sakineh Kazemi Noureini; Shoji Notomi; Lucia Notterpek; Karin Nowikovsky; Nobuyuki Nukina; Thorsten Nürnberger; Valerie B O'Donnell; Tracey O'Donovan; Peter J O'Dwyer; Ina Oehme; Clara L Oeste; Michinaga Ogawa; Besim Ogretmen; Yuji Ogura; Young J Oh; Masaki Ohmuraya; Takayuki Ohshima; Rani Ojha; Koji Okamoto; Toshiro Okazaki; F Javier Oliver; Karin Ollinger; Stefan Olsson; Daniel P Orban; Paulina Ordonez; Idil Orhon; Laszlo Orosz; Eyleen J O'Rourke; Helena Orozco; Angel L Ortega; Elena Ortona; Laura D Osellame; Junko Oshima; Shigeru Oshima; Heinz D Osiewacz; Takanobu Otomo; Kinya Otsu; Jing-Hsiung James Ou; Tiago F Outeiro; Dong-Yun Ouyang; Hongjiao Ouyang; Michael Overholtzer; Michelle A Ozbun; P Hande Ozdinler; Bulent Ozpolat; Consiglia Pacelli; Paolo Paganetti; Guylène Page; Gilles Pages; Ugo Pagnini; Beata Pajak; Stephen C Pak; Karolina Pakos-Zebrucka; Nazzy Pakpour; Zdena Palková; Francesca Palladino; Kathrin Pallauf; Nicolas Pallet; Marta Palmieri; Søren R Paludan; Camilla Palumbo; Silvia Palumbo; Olatz Pampliega; Hongming Pan; Wei Pan; Theocharis Panaretakis; Aseem Pandey; Areti Pantazopoulou; Zuzana Papackova; Daniela L Papademetrio; Issidora Papassideri; Alessio Papini; Nirmala Parajuli; Julian Pardo; Vrajesh V Parekh; Giancarlo Parenti; Jong-In Park; Junsoo Park; Ohkmae K Park; Roy Parker; Rosanna Parlato; Jan B Parys; Katherine R Parzych; Jean-Max Pasquet; Benoit Pasquier; Kishore Bs Pasumarthi; Daniel Patschan; Cam Patterson; Sophie Pattingre; Scott Pattison; Arnim Pause; Hermann Pavenstädt; Flaminia Pavone; Zully Pedrozo; Fernando J Peña; Miguel A Peñalva; Mario Pende; Jianxin Peng; Fabio Penna; Josef M Penninger; Anna Pensalfini; Salvatore Pepe; Gustavo Js Pereira; Paulo C Pereira; Verónica Pérez-de la Cruz; María Esther Pérez-Pérez; Diego Pérez-Rodríguez; Dolores Pérez-Sala; Celine Perier; Andras Perl; David H Perlmutter; Ida Perrotta; Shazib Pervaiz; Maija Pesonen; Jeffrey E Pessin; Godefridus J Peters; Morten Petersen; Irina Petrache; Basil J Petrof; Goran Petrovski; James M Phang; Mauro Piacentini; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Federico Pietrocola; Felipe X Pimentel-Muiños; Mario Pinar; Benjamin Pineda; Ronit Pinkas-Kramarski; Marcello Pinti; Paolo Pinton; Bilal Piperdi; James M Piret; Leonidas C Platanias; Harald W Platta; Edward D Plowey; Stefanie Pöggeler; Marc Poirot; Peter Polčic; Angelo Poletti; Audrey H Poon; Hana Popelka; Blagovesta Popova; Izabela Poprawa; Shibu M Poulose; Joanna Poulton; Scott K Powers; Ted Powers; Mercedes Pozuelo-Rubio; Krisna Prak; Reinhild Prange; Mark Prescott; Muriel Priault; Sharon Prince; Richard L Proia; Tassula Proikas-Cezanne; Holger Prokisch; Vasilis J Promponas; Karin Przyklenk; Rosa Puertollano; Subbiah Pugazhenthi; Luigi Puglielli; Aurora Pujol; Julien Puyal; Dohun Pyeon; Xin Qi; Wen-Bin Qian; Zheng-Hong Qin; Yu Qiu; Ziwei Qu; Joe Quadrilatero; Frederick Quinn; Nina Raben; Hannah Rabinowich; Flavia Radogna; Michael J Ragusa; Mohamed Rahmani; Komal Raina; Sasanka Ramanadham; Rajagopal Ramesh; Abdelhaq Rami; Sarron Randall-Demllo; Felix Randow; Hai Rao; V Ashutosh Rao; Blake B Rasmussen; Tobias M Rasse; Edward A Ratovitski; Pierre-Emmanuel Rautou; Swapan K Ray; Babak Razani; Bruce H Reed; Fulvio Reggiori; Markus Rehm; Andreas S Reichert; Theo Rein; David J Reiner; Eric Reits; Jun Ren; Xingcong Ren; Maurizio Renna; Jane Eb Reusch; Jose L Revuelta; Leticia Reyes; Alireza R Rezaie; Robert I Richards; Des R Richardson; Clémence Richetta; Michael A Riehle; Bertrand H Rihn; Yasuko Rikihisa; Brigit E Riley; Gerald Rimbach; Maria Rita Rippo; Konstantinos Ritis; Federica Rizzi; Elizete Rizzo; Peter J Roach; Jeffrey Robbins; Michel Roberge; Gabriela Roca; Maria Carmela Roccheri; Sonia Rocha; Cecilia Mp Rodrigues; Clara I Rodríguez; Santiago Rodriguez de Cordoba; Natalia Rodriguez-Muela; Jeroen Roelofs; Vladimir V Rogov; Troy T Rohn; Bärbel Rohrer; Davide Romanelli; Luigina Romani; Patricia Silvia Romano; M Isabel G Roncero; Jose Luis Rosa; Alicia Rosello; Kirill V Rosen; Philip Rosenstiel; Magdalena Rost-Roszkowska; Kevin A Roth; Gael Roué; Mustapha Rouis; Kasper M Rouschop; Daniel T Ruan; Diego Ruano; David C Rubinsztein; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Ruediger Rudolf; Markus A Ruegg; Carmen Ruiz-Roldan; Avnika Ashok Ruparelia; Paola Rusmini; David W Russ; Gian Luigi Russo; Giuseppe Russo; Rossella Russo; Tor Erik Rusten; Victoria Ryabovol; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Michael Sacher; Carsten Sachse; Michael N Sack; Junichi Sadoshima; Paul Saftig; Ronit Sagi-Eisenberg; Sumit Sahni; Pothana Saikumar; Tsunenori Saito; Tatsuya Saitoh; Koichi Sakakura; Machiko Sakoh-Nakatogawa; Yasuhito Sakuraba; María Salazar-Roa; Paolo Salomoni; Ashok K Saluja; Paul M Salvaterra; Rosa Salvioli; Afshin Samali; Anthony Mj Sanchez; José A Sánchez-Alcázar; Ricardo Sanchez-Prieto; Marco Sandri; Miguel A Sanjuan; Stefano Santaguida; Laura Santambrogio; Giorgio Santoni; Claudia Nunes Dos Santos; Shweta Saran; Marco Sardiello; Graeme Sargent; Pallabi Sarkar; Sovan Sarkar; Maria Rosa Sarrias; Minnie M Sarwal; Chihiro Sasakawa; Motoko Sasaki; Miklos Sass; Ken Sato; Miyuki Sato; Joseph Satriano; Niramol Savaraj; Svetlana Saveljeva; Liliana Schaefer; Ulrich E Schaible; Michael Scharl; Hermann M Schatzl; Randy Schekman; Wiep Scheper; Alfonso Schiavi; Hyman M Schipper; Hana Schmeisser; Jens Schmidt; Ingo Schmitz; Bianca E Schneider; E Marion Schneider; Jaime L Schneider; Eric A Schon; Miriam J Schönenberger; Axel H Schönthal; Daniel F Schorderet; Bernd Schröder; Sebastian Schuck; Ryan J Schulze; Melanie Schwarten; Thomas L Schwarz; Sebastiano Sciarretta; Kathleen Scotto; A Ivana Scovassi; Robert A Screaton; Mark Screen; Hugo Seca; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Jose M Seguí-Simarro; Juan Segura-Aguilar; Ekihiro Seki; Christian Sell; Iban Seiliez; Clay F Semenkovich; Gregg L Semenza; Utpal Sen; Andreas L Serra; Ana Serrano-Puebla; Hiromi Sesaki; Takao Setoguchi; Carmine Settembre; John J Shacka; Ayesha N Shajahan-Haq; Irving M Shapiro; Shweta Sharma; Hua She; C-K James Shen; Chiung-Chyi Shen; Han-Ming Shen; Sanbing Shen; Weili Shen; Rui Sheng; Xianyong Sheng; Zu-Hang Sheng; Trevor G Shepherd; Junyan Shi; Qiang Shi; Qinghua Shi; Yuguang Shi; Shusaku Shibutani; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Dong Wook Shin; Mari L Shinohara; Michiko Shintani; Takahiro Shintani; Tetsuo Shioi; Ken Shirabe; Ronit Shiri-Sverdlov; Orian Shirihai; Gordon C Shore; Chih-Wen Shu; Deepak Shukla; Andriy A Sibirny; Valentina Sica; Christina J Sigurdson; Einar M Sigurdsson; Puran Singh Sijwali; Beata Sikorska; Wilian A Silveira; Sandrine Silvente-Poirot; Gary A Silverman; Jan Simak; Thomas Simmet; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Matias Simons; Anne Simonsen; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Debasish Sinha; Sangita Sinha; Frank A Sinicrope; Agnieszka Sirko; Kapil Sirohi; Balindiwe Jn Sishi; Annie Sittler; Parco M Siu; Efthimios Sivridis; Anna Skwarska; Ruth Slack; Iva Slaninová; Nikolai Slavov; Soraya S Smaili; Keiran Sm Smalley; Duncan R Smith; Stefaan J Soenen; Scott A Soleimanpour; Anita Solhaug; Kumaravel Somasundaram; Jin H Son; Avinash Sonawane; Chunjuan Song; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Wei Song; Kai Y Soo; Anil K Sood; Tuck Wah Soong; Virawudh Soontornniyomkij; Maurizio Sorice; Federica Sotgia; David R Soto-Pantoja; Areechun Sotthibundhu; Maria João Sousa; Herman P Spaink; Paul N Span; Anne Spang; Janet D Sparks; Peter G Speck; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Daret St Clair; Alessandra Stacchiotti; Bart Staels; Michael T Stang; Daniel T Starczynowski; Petro Starokadomskyy; Clemens Steegborn; John W Steele; Leonidas Stefanis; Joan Steffan; Christine M Stellrecht; Harald Stenmark; Tomasz M Stepkowski; Stęphan T Stern; Craig Stevens; Brent R Stockwell; Veronika Stoka; Zuzana Storchova; Björn Stork; Vassilis Stratoulias; Dimitrios J Stravopodis; Pavel Strnad; Anne Marie Strohecker; Anna-Lena Ström; Per Stromhaug; Jiri Stulik; Yu-Xiong Su; Zhaoliang Su; Carlos S Subauste; Srinivasa Subramaniam; Carolyn M Sue; Sang Won Suh; Xinbing Sui; Supawadee Sukseree; David Sulzer; Fang-Lin Sun; Jiaren Sun; Jun Sun; Shi-Yong Sun; Yang Sun; Yi Sun; Yingjie Sun; Vinod Sundaramoorthy; Joseph Sung; Hidekazu Suzuki; Kuninori Suzuki; Naoki Suzuki; Tadashi Suzuki; Yuichiro J Suzuki; Michele S Swanson; Charles Swanton; Karl Swärd; Ghanshyam Swarup; Sean T Sweeney; Paul W Sylvester; Zsuzsanna Szatmari; Eva Szegezdi; Peter W Szlosarek; Heinrich Taegtmeyer; Marco Tafani; Emmanuel Taillebourg; Stephen Wg Tait; Krisztina Takacs-Vellai; Yoshinori Takahashi; Szabolcs Takáts; Genzou Takemura; Nagio Takigawa; Nicholas J Talbot; Elena Tamagno; Jerome Tamburini; Cai-Ping Tan; Lan Tan; Mei Lan Tan; Ming Tan; Yee-Joo Tan; Keiji Tanaka; Masaki Tanaka; Daolin Tang; Dingzhong Tang; Guomei Tang; Isei Tanida; Kunikazu Tanji; Bakhos A Tannous; Jose A Tapia; Inmaculada Tasset-Cuevas; Marc Tatar; Iman Tavassoly; Nektarios Tavernarakis; Allen Taylor; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Mark J Taylor; Elena V Tchetina; Andrew R Tee; Fatima Teixeira-Clerc; Sucheta Telang; Tewin Tencomnao; Ba-Bie Teng; Ru-Jeng Teng; Faraj Terro; Gianluca Tettamanti; Arianne L Theiss; Anne E Theron; Kelly Jean Thomas; Marcos P Thomé; Paul G Thomes; Andrew Thorburn; Jeremy Thorner; Thomas Thum; Michael Thumm; Teresa Lm Thurston; Ling Tian; Andreas Till; Jenny Pan-Yun Ting; Vladimir I Titorenko; Lilach Toker; Stefano Toldo; Sharon A Tooze; Ivan Topisirovic; Maria Lyngaas Torgersen; Liliana Torosantucci; Alicia Torriglia; Maria Rosaria Torrisi; Cathy Tournier; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Gemma Triola; Durga Nand Tripathi; Daniela Trisciuoglio; Rodrigo Troncoso; Ioannis P Trougakos; Anita C Truttmann; Kuen-Jer Tsai; Mario P Tschan; Yi-Hsin Tseng; Takayuki Tsukuba; Allan Tsung; Andrey S Tsvetkov; Shuiping Tu; Hsing-Yu Tuan; Marco Tucci; David A Tumbarello; Boris Turk; Vito Turk; Robin Fb Turner; Anders A Tveita; Suresh C Tyagi; Makoto Ubukata; Yasuo Uchiyama; Andrej Udelnow; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Benjamin R Underwood; Christian Ungermann; Rodrigo P Ureshino; Ryo Ushioda; Vladimir N Uversky; Néstor L Uzcátegui; Thomas Vaccari; Maria I Vaccaro; Libuše Váchová; Helin Vakifahmetoglu-Norberg; Rut Valdor; Enza Maria Valente; Francois Vallette; Angela M Valverde; Greet Van den Berghe; Ludo Van Den Bosch; Gijs R van den Brink; F Gisou van der Goot; Ida J van der Klei; Luc Jw van der Laan; Wouter G van Doorn; Marjolein van Egmond; Kenneth L van Golen; Luc Van Kaer; Menno van Lookeren Campagne; Peter Vandenabeele; Wim Vandenberghe; Ilse Vanhorebeek; Isabel Varela-Nieto; M Helena Vasconcelos; Radovan Vasko; Demetrios G Vavvas; Ignacio Vega-Naredo; Guillermo Velasco; Athanassios D Velentzas; Panagiotis D Velentzas; Tibor Vellai; Edo Vellenga; Mikkel Holm Vendelbo; Kartik Venkatachalam; Natascia Ventura; Salvador Ventura; Patrícia St Veras; Mireille Verdier; Beata G Vertessy; Andrea Viale; Michel Vidal; Helena L A Vieira; Richard D Vierstra; Nadarajah Vigneswaran; Neeraj Vij; Miquel Vila; Margarita Villar; Victor H Villar; Joan Villarroya; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Giovanni Vitale; Dan T Vogl; Olga V Voitsekhovskaja; Clarissa von Haefen; Karin von Schwarzenberg; Daniel E Voth; Valérie Vouret-Craviari; Kristina Vuori; Jatin M Vyas; Christian Waeber; Cheryl Lyn Walker; Mark J Walker; Jochen Walter; Lei Wan; Xiangbo Wan; Bo Wang; Caihong Wang; Chao-Yung Wang; Chengshu Wang; Chenran Wang; Chuangui Wang; Dong Wang; Fen Wang; Fuxin Wang; Guanghui Wang; Hai-Jie Wang; Haichao Wang; Hong-Gang Wang; Hongmin Wang; Horng-Dar Wang; Jing Wang; Junjun Wang; Mei Wang; Mei-Qing Wang; Pei-Yu Wang; Peng Wang; Richard C Wang; Shuo Wang; Ting-Fang Wang; Xian Wang; Xiao-Jia Wang; Xiao-Wei Wang; Xin Wang; Xuejun Wang; Yan Wang; Yanming Wang; Ying Wang; Ying-Jan Wang; Yipeng Wang; Yu Wang; Yu Tian Wang; Yuqing Wang; Zhi-Nong Wang; Pablo Wappner; Carl Ward; Diane McVey Ward; Gary Warnes; Hirotaka Watada; Yoshihisa Watanabe; Kei Watase; Timothy E Weaver; Colin D Weekes; Jiwu Wei; Thomas Weide; Conrad C Weihl; Günther Weindl; Simone Nardin Weis; Longping Wen; Xin Wen; Yunfei Wen; Benedikt Westermann; Cornelia M Weyand; Anthony R White; Eileen White; J Lindsay Whitton; Alexander J Whitworth; Joëlle Wiels; Franziska Wild; Manon E Wildenberg; Tom Wileman; Deepti Srinivas Wilkinson; Simon Wilkinson; Dieter Willbold; Chris Williams; Katherine Williams; Peter R Williamson; Konstanze F Winklhofer; Steven S Witkin; Stephanie E Wohlgemuth; Thomas Wollert; Ernst J Wolvetang; Esther Wong; G William Wong; Richard W Wong; Vincent Kam Wai Wong; Elizabeth A Woodcock; Karen L Wright; Chunlai Wu; Defeng Wu; Gen Sheng Wu; Jian Wu; Junfang Wu; Mian Wu; Min Wu; Shengzhou Wu; William Kk Wu; Yaohua Wu; Zhenlong Wu; Cristina Pr Xavier; Ramnik J Xavier; Gui-Xian Xia; Tian Xia; Weiliang Xia; Yong Xia; Hengyi Xiao; Jian Xiao; Shi Xiao; Wuhan Xiao; Chuan-Ming Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Yuyan Xiong; Chuanshan Xu; Congfeng Xu; Feng Xu; Haoxing Xu; Hongwei Xu; Jian Xu; Jianzhen Xu; Jinxian Xu; Liang Xu; Xiaolei Xu; Yangqing Xu; Ye Xu; Zhi-Xiang Xu; Ziheng Xu; Yu Xue; Takahiro Yamada; Ai Yamamoto; Koji Yamanaka; Shunhei Yamashina; Shigeko Yamashiro; Bing Yan; Bo Yan; Xianghua Yan; Zhen Yan; Yasuo Yanagi; Dun-Sheng Yang; Jin-Ming Yang; Liu Yang; Minghua Yang; Pei-Ming Yang; Peixin Yang; Qian Yang; Wannian Yang; Wei Yuan Yang; Xuesong Yang; Yi Yang; Ying Yang; Zhifen Yang; Zhihong Yang; Meng-Chao Yao; Pamela J Yao; Xiaofeng Yao; Zhenyu Yao; Zhiyuan Yao; Linda S Yasui; Mingxiang Ye; Barry Yedvobnick; Behzad Yeganeh; Elizabeth S Yeh; Patricia L Yeyati; Fan Yi; Long Yi; Xiao-Ming Yin; Calvin K Yip; Yeong-Min Yoo; Young Hyun Yoo; Seung-Yong Yoon; Ken-Ichi Yoshida; Tamotsu Yoshimori; Ken H Young; Huixin Yu; Jane J Yu; Jin-Tai Yu; Jun Yu; Li Yu; W Haung Yu; Xiao-Fang Yu; Zhengping Yu; Junying Yuan; Zhi-Min Yuan; Beatrice Yjt Yue; Jianbo Yue; Zhenyu Yue; David N Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Tania Zaglia; Zahra Zakeri; Vincent Zecchini; Jinsheng Zeng; Min Zeng; Qi Zeng; Antonis S Zervos; Donna D Zhang; Fan Zhang; Guo Zhang; Guo-Chang Zhang; Hao Zhang; Hong Zhang; Hong Zhang; Hongbing Zhang; Jian Zhang; Jian Zhang; Jiangwei Zhang; Jianhua Zhang; Jing-Pu Zhang; Li Zhang; Lin Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xiangnan Zhang; Xu Dong Zhang; Yan Zhang; Yang Zhang; Yanjin Zhang; Yingmei Zhang; Yunjiao Zhang; Mei Zhao; Wei-Li Zhao; Xiaonan Zhao; Yan G Zhao; Ying Zhao; Yongchao Zhao; Yu-Xia Zhao; Zhendong Zhao; Zhizhuang J Zhao; Dexian Zheng; Xi-Long Zheng; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Guang-Zhou Zhou; Guofei Zhou; Huiping Zhou; Shu-Feng Zhou; Xu-Jie Zhou; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Wenhua Zhu; Xiao-Feng Zhu; Yuhua Zhu; Shi-Mei Zhuang; Xiaohong Zhuang; Elio Ziparo; Christos E Zois; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Susu M Zughaier Journal: Autophagy Date: 2016 Impact factor: 16.016
Authors: Kristin L Rosche; Lindsay C Sidak-Loftis; Joanna Hurtado; Elizabeth A Fisk; Dana K Shaw Journal: Front Immunol Date: 2021-02-15 Impact factor: 8.786